SCHEMBL694356

SCHEMBL694356

[c]1ccc2[nH]c(-c3cccnc3)cc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.68
CLK2 P49760 2/20 0.45
CLK3 P49761 2/20 0.45
DYRK1A Q13627 2/20 0.45
CYP2A6 P11509 4/20 0.43
CYP3A4 P08684 3/20 0.42
CYP2E1 P05181 2/20 0.42
CYP2B6 P20813 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 1/20 0.42
STAT1 P42224 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL693900 0.83 CYP19A1 (0.44) CYP19A1CLK2CLK3DYRK1ACYP2C9
SCHEMBL29790209 0.81 CYP19A1 (1.00) CYP19A1CLK2CLK3DYRK1ACYP2C9
SCHEMBL2789486 0.81 CYP19A1 (1.00) CYP19A1CLK2CLK3DYRK1ACYP2C9
SCHEMBL693863 0.81 CLK1 (0.42) CYP19A1CYP2C9CYP2C19ALDH1A1NPC1
SCHEMBL694898 0.80 NPC1 (0.63) CYP19A1CYP2D6CYP2C9CYP2C19ALDH1A1
Hydrochloric Acid SCHEMBL27830550 0.80 CYP19A1 (0.97) CYP19A1CLK2CLK3DYRK1ACYP2C9
SCHEMBL694550 0.79 HPGDS (0.44) CYP19A1CYP2C9CYP2C19ALDH1A1NPC1
SCHEMBL31317820 0.78 CYP19A1 (0.71) CYP19A1CLK2CLK3DYRK1ACYP2A6
SCHEMBL21812408 0.78 CYP19A1 (0.71) CYP19A1CLK2CLK3DYRK1ACYP2A6
SCHEMBL4278217 0.76 METAP2 (0.40) CYP19A1CLK2CLK3DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed